N/A (healthy adults)
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: -Postmenopausal women -Individuals who have the symptoms of finger joint that do not require treatment
Exclusion criteria
Exclusion criteria: -Individuals who are under medical treatment -Individuals who receiving hormone replacement treatment or using Chinese medicine for menopausal symptoms within the past six months -Individuals who regularly use painkillers -Individuals who have history of rheumatoid arthritis and other collagen diseases -Individuals who are allergic to food or medicine -Individuals who are diagnosed as inappropriate for the trial by the principal Investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The change percentage of visual analog scale from baseline at 12 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| -The changes in VAS, scores and number of joints of fingers with pain and discomfort from baseline to 4, 8, and 12 weeks -The Changes in finger condition and physical condition from baseline at 12 weeks -Adverse events and side effects that occurred between the start of ingestion and the end of the post-observation period or at the time of discontinuation | — |
Countries
Japan
Contacts
TES Holdings CO., Ltd. Administrative Department of Clinical Trials